PolyPeptide Group Revenue and Competitors
Estimated Revenue & Valuation
- PolyPeptide Group's estimated annual revenue is currently $312.6M per year.
- PolyPeptide Group's estimated revenue per employee is $201,000
Employee Data
- PolyPeptide Group has 1555 Employees.
- PolyPeptide Group grew their employee count by 17% last year.
PolyPeptide Group's People
Name | Title | Email/Phone |
---|---|---|
1 | Service Owner Identity & Access Management | Reveal Email/Phone |
2 | Service Owner Microsoft 365 | Reveal Email/Phone |
3 | Head Production - Down Stream | Reveal Email/Phone |
4 | Head Production | Reveal Email/Phone |
5 | Head & Manager - R&D/AD | Reveal Email/Phone |
6 | Head Program Management | Reveal Email/Phone |
7 | Head Development | Reveal Email/Phone |
8 | Production Officer | Reveal Email/Phone |
9 | Officer | Reveal Email/Phone |
10 | Head Manufacturing | Reveal Email/Phone |
PolyPeptide Group Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $102.7M | 511 | 25% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $38.6M | 192 | 3% | N/A | N/A |
#4 | $35M | 127 | 2% | $62.5M | N/A |
#5 | $36.6M | 182 | 18% | N/A | N/A |
#6 | $131.9M | 656 | -3% | N/A | N/A |
#7 | $133.5M | 664 | N/A | N/A | N/A |
#8 | $72.8M | 362 | -4% | N/A | N/A |
#9 | $551.9M | 1716 | -2% | N/A | N/A |
#10 | $11.7M | 58 | 12% | N/A | N/A |
What Is PolyPeptide Group?
PolyPeptide Laboratories specializes in developing small- and large-scale production processes for proprietary peptides. Whether you require gram or multi-kilogram quantities, we can support your custom project at every step, even with the most complex peptides. The evidence is in our track record, with hundreds of successful projects over the years.
keywords:N/AN/A
Total Funding
1555
Number of Employees
$312.6M
Revenue (est)
17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
PolyPeptide Group News
... Pfizer, Inc., Sanofi, Takeda Pharmaceutical Company Limited and Teva ... Novo Nordisk A/S; PolyPeptide Group; CordenPharma International.
... Pfizer, Inc., Sanofi, Takeda Pharmaceutical Company Limited and ... Novo Nordisk A/S; PolyPeptide Group; CordenPharma International;...
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by...
EQS Group-Ad-hoc: PolyPeptide Group / Key word(s): Personnel PolyPeptide Group appoints Christina Del Vecchio as General Counsel and member of the Executive Committee 25-Jun-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for th ...
EQS Group-News: PolyPeptide Group / Key word(s): IPO PolyPeptide Group launches IPO on the Swiss Stock Exchange and sets price range at CHF 57 to CHF 68 per share 21.04.2021 / 07:00 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $311.5M | 1556 | -2% | $20M |
#2 | $317.5M | 1564 | N/A | N/A |
#3 | $539M | 1565 | N/A | N/A |
#4 | $75M | 1571 | 8% | N/A |
#5 | $318.1M | 1589 | 0% | $446.5M |